| 1 |
Quality risk assessment and DoE-based analytical quality by design approach to stability-indicating assay method for acidic degradation kinetic study of apremilast |
|
| | Pintu Prajapati,Hitika Patel,Shailesh Shah | | | JPC – Journal of Planar Chromatography – Modern TLC. 2020; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Analytical Methods for Determination of Apremilast from Bulk, Dosage Form and Biological Fluids: A Critical Review |
|
| | Pooja Kulkarni,Ashwini Deshpande | | | Critical Reviews in Analytical Chemistry. 2020; : 1 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Apremilast in chronic recalcitrant erythema nodosum leprosum: a report of two cases |
|
| | T. Narang,A. Kaushik,S. Dogra | | | British Journal of Dermatology. 2019; | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Viva voce on apremilast |
|
| | UdayS Khopkar,KinjalDeepak Rambhia | | | Indian Journal of Drugs in Dermatology. 2019; 5(1): 63 | | | [Pubmed] [Google Scholar] [DOI] | |
|
